Metallothionein MT2A A-5G Polymorphism and the Risk for Chronic Kidney Disease and Diabetes

被引：0
|
作者：
Kawada, Tomoyuki [1 ]
机构：
[1] Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan
来源：
TOXICOLOGICAL SCIENCES | 2016年 / 154卷 / 02期
关键词：
D O I：
10.1093/toxsci/kfw205
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [31] CHRONIC KIDNEY DISEASE IS A TYPE 2 DIABETES RISK EQUIVALENT IN PATIENTS WITH ESTABLISHED CORONARY ARTERY DISEASE
    Saely, Christoph H.
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Maechler, Maximilian
    Mutschlechner, Beatrix
    Zanolin-Purin, Daniela
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1513 - 1513
  • [32] Chronic kidney disease is a type 2 diabetes risk equivalent in patients with established coronary artery disease
    Saely, Christoph H.
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Maechler, Maximilian
    Zanolin-Purin, Daniela
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S352 - S352
  • [33] CHRONIC KIDNEY DISEASE IS A TYPE 2 DIABETES RISK EQUIVALENT IN PATIENTS WITH ESTABLISHED CORONARY ARTERY DISEASE
    Saely, C. H.
    Sprenger, L.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Maechler, M.
    Mutschlechner, B.
    Zanolin-Purin, D.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    ATHEROSCLEROSIS, 2021, 331 : E234 - E234
  • [34] Chronic Kidney Disease Is a Type 2 Diabetes Risk Equivalent in Patients with Established Coronary Artery Disease
    Saely, Christoph H.
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Maechler, Maximilian
    Purin, Daniela
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    DIABETES, 2020, 69
  • [35] Chronic kidney disease is a type 2 diabetes risk equivalent in patients with established coronary artery disease
    Saely, C. H.
    Sprenger, L.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Maechler, M.
    Zanolin-Purin, D.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S312 - S312
  • [36] Chronic kidney disease is a type 2 diabetes risk equivalent in patients with established coronary artery disease
    Saely, C. H.
    Sprenger, L.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Maechler, M.
    Zanolin-Purin, D.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S439 - S439
  • [37] Semaglutide for Chronic Kidney Disease in Type 2 Diabetes
    Passos, Rogerio da Hora
    Narciso, Roberto Camargo
    da Silva, Arnaldo Alves
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (18): : 1757 - 1757
  • [38] Management of type 2 diabetes in chronic kidney disease
    Triozzi, Jefferson L.
    Parker Gregg, L.
    Virani, Salim S.
    Navaneethan, Sankar D.
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [39] Is chronic kidney disease comparable to diabetes as a coronary artery disease risk factor?
    Rashidi, Arash
    Ghanbarian, Arash
    Azizi, Fereidoun
    Adler, Dale S.
    SOUTHERN MEDICAL JOURNAL, 2007, 100 (01) : 20 - 26
  • [40] Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study
    Chu, Lisa
    Fuller, Mark
    Jervis, Kathyrn
    Ciaccia, Antonio
    Abitbol, Alexander
    CLINICAL THERAPEUTICS, 2021, 43 (09) : 1558 - +
12345